TP53 and nasopharyngeal carcinoma: Meta-analytical evidence by Yang et al., encompassing studies of 1189 patients, underscores a significant association between positive TP53 status and diminished 5-year survival rates in NPC patients, thereby affirming TP53’s relevance in NPC prognosis and treatment strategies (44).